including an indirect ELISA ( iELISA ) ; a highly specific monoclonal antibody-based blocking ELISA ( bELISA ) ; fluorescent microsphere immunoassays ( FMIA ) that can be multiplexed to monitor exposure to multiple antigens and pathogens simultaneously ; and a fluorescent focus neutralization assay ( FFN ) to measure functional virus neutralizing antibodies.